What SBI Healthcare Opportunities Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of SBI Mutual Fund.
SBI Healthcare Opportunities Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Aurobindo Pharma Ltd. | Reduced | −9.0% | 3.42% |
|---|---|---|---|
| Corona Remedies Ltd. | New | New | 2.43% |
| Aether Industries Ltd. | Reduced | −6.2% | 2.17% |
| Ajanta Pharma Ltd. | Reduced | −3.2% | 1.79% |
| Healthcare Global Enterprises Ltd. | Added | +50.0% | 1.70% |
| Innova Captab Ltd. | New | New | 1.65% |
| Dr. Lal Path labs Ltd. | Added | +9.1% | 1.62% |
| Abbott India Ltd. | Reduced | −35.6% | 0.23% |
| Novartis India Ltd. | New | New | 0.04% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did SBI Healthcare Opportunities Fund buy in September 2026?
It bought 3 new stocks: Corona Remedies Ltd (2.43%), Innova Captab Ltd (1.65%) and Novartis India Ltd (0.04%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did SBI Healthcare Opportunities Fund sell completely in September 2026?
SBI Healthcare Opportunities Fund did not sell any stock completely in September 2026.
Which stocks did SBI Healthcare Opportunities Fund buy more of in September 2026?
The largest increases in shares held were Healthcare Global Enterprises Ltd (+50.0%) and Dr. Lal Path labs Ltd (+9.1%).
Which stocks did SBI Healthcare Opportunities Fund sell part of in September 2026?
The largest cuts in shares held were Abbott India Ltd (−35.6%), Aurobindo Pharma Ltd (−9.0%), Aether Industries Ltd (−6.2%) and Ajanta Pharma Ltd (−3.2%).
How are these changes worked out?
WealthGamma compares the number of shares SBI Healthcare Opportunities Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of SBI Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of SBI Healthcare Opportunities Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.